Failure Criteria of Artificial Joints: A review

Abstract

Artificial joint replacement is one of the most essential arthroplasty for sever diseases of human joints. This surgical treatment involves the replacement of native articulating joints, such as the knee, hip, ankle, and shoulder with artificial components. Currently, it is assumed that there are well over one million artificial joints implanted yearly into patients world-wide [1,2]. By 2030, there may be 500, 000 total hip arthroplasty (THA) and 3 million total knee arthroplasty (TKA) cases per year [3,4]. Various biomaterial combinations include metals, ceramics, carbon and synthetic polymers are now used in biomedical applications.